Cerevel Therapeutics Holdings Inc. (CERE)

Trade CERE now with
12/8/2020 7:23:12 AM Cerevel Therapeutics Names Ruth McKernan To Board
6/17/2016 9:00:29 AM Land O’Lakes To Acquire Ceres, Inc. In Cash Tender Offer
4/26/2016 7:20:28 AM Ceres Awarded Two U.S. Patents For Innovative Crop Traits
4/18/2016 7:37:05 AM Ceres Expands Distribution Network For Its Forage Sorghum Seed Products
4/14/2016 4:06:19 PM Ceres Q2 Loss/share $0.09 Vs. Loss $1.34 Year Ago
2/17/2016 7:06:59 AM Ceres Says Petition To Have Number Of Its Traits For Corn Deemed Non-regulated Successful
1/14/2016 4:09:45 PM Ceres Posts Q1 Loss/share Of $0.39 Vs. Loss $0.96 Year Ago
12/15/2015 8:33:16 AM Ceres Prices Public Offering Of Units For Gross Proceeds Of $6.7 Mln
9/29/2015 7:33:50 AM KWS SAAT To Evaluate Ceres' Persephone Bioinformatics Technology Under License Agreement
8/21/2015 9:12:53 AM Ceres Announces Pricing Of $2.1 Mln At-the-Market Registered Direct Offering And Private Placement
8/12/2015 7:32:54 AM Ceres Awarded Patent For ICODE Trait Development System
7/27/2015 9:06:48 AM Ceres Enters Securities Purchase Agreement With Certain Institutional Investors
7/10/2015 4:09:02 PM Ceres Reports Q3 Loss Per Share Of $0.98 Vs. $1.35 Last Year
6/19/2015 7:50:18 AM Ceres To Restructure Its Brazilian Seed Operations; Expects To Save Up To $6 Mln To $8 Mln Next Fiscal Year
4/9/2015 4:49:24 PM Ceres Q2 Loss Widens
4/9/2015 4:09:10 PM Ceres Q2 Loss Per Share $1.34 Vs. $2.29 Last Year
4/8/2015 4:57:59 PM Ceres Announces One-For-Eight Reverse Stock Split